查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829650

2025年全球避孕设备市场报告

Contraceptive Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，避孕设备市场规模强劲成长，从2024年的128亿美元增加至2025年的135.5亿美元，复合年增长率为5.9%。这段历史时期的成长可归因于人们对计划生育和避孕重要性的认识不断提高、政府倡议、全球人口增长、对女性健康和赋权的日益关注以及医疗设施可及性的改善。

预计未来几年避孕设备市场规模将强劲成长，到2029年将达到172.5亿美元，复合年增长率为6.2%。预测期内的成长可归因于人们对性健康和性传播疾病预防意识的提高、控製家庭规模的经济效益、避孕器文化接受度的提高、育龄青年比例的提高以及社交媒体在传播避孕意识方面的影响力。预测期内的主要趋势包括避孕技术的创新、非政府组织和卫生组织的教育宣传活动、药物配方的进步、避孕产品的普及以及对新型避孕方法研发的投资。

避孕药具是用来预防怀孕的医疗器材。避孕器具种类繁多，每种避孕机制和效果各不相同。这些装置主要用于预防意外怀孕，在某些情况下也用于预防性性行为感染(STI)。

避孕器具的主要类型包括男性避孕药、女性用避孕药、女性用保险套、隔膜和海绵、避孕环、子宫内避孕器和皮下植入。男用避孕器具是男性用来预防怀孕的方法，例如保险套和输精管结扎。这些避孕器具包括荷尔蒙避孕法和屏障避孕法。这些器具透过各种管道分销，包括医院药房、零售药房、诊所、线上平台、公共管道和非政府组织 (NGO)。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供避孕设备市场统计数据，例如全球市场规模、区域份额、避孕设备市场份额竞争对手、详细的避孕设备细分市场、市场趋势和商业机会，以及您在避孕设备行业取得成功所需的数据。本避孕设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切全面观点。

未来五年6.2%的预测成长率比我们先前对该市场的预测略有下降，下降了0.1%。下降的主要原因是美国与其他国家之间关税的影响。美国可能会直接感受到关税的影响，因为这些避孕器来自荷兰和爱尔兰等主要地区，这可能导致计划生育选择减少，生殖健康成本上升。此外，关税的互惠效应以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，可能会对全球经济和贸易产生更广泛的负面影响。

性行为感染传染病 (STD) 的日益普及预计将推动避孕器市场的成长。性感染疾病主要透过性接触传播，影响身体的各个部位，并可能导致各种症状和健康问题。性传染病流行率的上升与性活动活性化、保护措施不足、性教育不足以及难以获得医疗保健和检测等因素有关。避孕装置，尤其是保险套，对于预防性传染病至关重要，因为它们透过防止直接接触传染性体液和病变部位，形成一道屏障，降低感染风险。例如，根据英国卫生安全局 2024 年 7 月的报告，2023 年英格兰新诊断的性传染感染病例为 401,800 例，比前一年的 383,789 例增加了 4.7%。预计淋病诊断数量将从 2022 年的 79,268 例增加 7.5% 至 2023 年的 85,223 例，而传染性梅毒诊断数量预计将从 2022 年的 8,693 例增加 9.4% 至 2023 年的 9,513 例。性传染病盛行率的上升正在推动对避孕设备的需求。

避孕设备市场中的公司正专注于开发创新产品，例如避孕避孕环。产品每月放置一次，即可提供便利、低维护的避孕效果。避孕避孕环是一种佩戴在阴道内的软性荷尔蒙释放装置。它透过持续释放抑制排卵和增稠子宫颈黏液的激素来防止怀孕。例如，2023年10月，美国製药公司Xiromed LLC宣布推出Eniroring。这款由Xiromed开发的避孕避孕环结合了依托孕烯和炔雌醇，旨在长期使用，在佩戴三週后停用一周。

2023年12月，美国生命科学公司Aditxt以1亿美元收购了Evofem Biosciences。此次收购涵盖了Evofem已获FDA核准的无激素避孕凝胶Phexxi®（乳酸、柠檬酸、酒石酸钾）。 Aditxt旨在透过此次收购，加强其在自体免疫、健康指标、延长寿命的移植技术、人口健康和女性健康领域的创新。此次收购增强了Aditxt的合作生态系统，并最大限度地发挥了其子公司的潜力。 Evofem Biosciences是美国避孕设备製造商。

避孕设备市场包括子宫颈帽、荷尔蒙注射、紧急避孕设备和避孕产品的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球避孕药具：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球避孕设备市场：成长率分析
  • 全球避孕设备市场表现：规模与成长，2019-2024
  • 全球避孕设备市场预测：2024-2029年、2034年规模与成长
  • 全球避孕设备：总目标市场（TAM）

第六章 市场细分

  • 全球避孕设备市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 男性避孕器
  • 女性用避孕器
  • 女性用保险套、隔膜、海绵
  • 避孕环
  • 子宫内避孕器
  • 皮下植入
  • 其他产品类型
  • 全球避孕设备市场技术、性能及预测（2019-2024、2024-2029、2034）
  • 荷尔蒙避孕药
  • 工具避孕
  • 全球避孕设备市场依通路划分：2019-2024 年、2024-2029 年、2034 年实际资料及预测
  • 医院药房
  • 零售药局
  • 诊所
  • 线上管道
  • 公共管道和非政府组织（NGO）
  • 其他分销管道
  • 全球避孕设备市场：男性避孕器的细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 男用保险套
  • 输精管切除器械
  • 男性避孕注射剂
  • 男性避孕药
  • 全球避孕设备市场：女性用避孕器细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 女性用保险套
  • 隔膜和海绵
  • 避孕环
  • 子宫内避孕器（IUD）
  • 皮下植入
  • 紧急避孕器
  • 全球避孕设备市场：女性用保险套细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 乳胶女性用保险套
  • 非乳胶女性用保险套
  • 全球避孕设备市场：依隔膜及海绵细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 硅振膜
  • 乳胶隔膜
  • 避孕海绵
  • 全球避孕设备市场：避孕环细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • NuvaRing（和其他荷尔蒙避孕环）
  • 非荷尔蒙避孕环
  • 全球避孕设备市场：子宫内避孕器（IUD）细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 铜子宫内避孕器
  • 荷尔蒙子宫内避孕器
  • 非荷尔蒙子宫内避孕器
  • 全球避孕设备市场：皮下植入物细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 荷尔蒙植入
  • 非荷尔蒙植入
  • 全球避孕设备市场：按其他产品类型细分（按类型）、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 避孕贴片
  • 避孕注射
  • 避孕药
  • 避孕凝胶和乳膏

第七章 区域和国家分析

  • 全球避孕设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球避孕设备市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 避孕设备市场：竞争格局
  • 避孕设备市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Mylan NV
  • Organon Group
  • Hologic Inc.
  • CooperSurgical Inc.
  • Cipla Inc.
  • Mankind Pharma Ltd.
  • TTK HealthCare Ltd.
  • Zondervan
  • Merck Sharp & Dohme Corp.
  • Evofem Biosciences Inc.
  • Veru Inc.
  • Medisafe Inc.
  • Agile Therapeutics Inc.
  • Janssen Global Services LLC
  • HLL Lifecare Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年避孕设备市场：提供新机会的国家
  • 2029年避孕设备市场：细分市场将带来新机会
  • 2029年避孕设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29886u

Contraceptive devices are medical tools designed to prevent pregnancy. They come in various forms, each with distinct mechanisms and levels of effectiveness. These devices are primarily used to avoid unintended pregnancies and, in some cases, offer protection against sexually transmitted infections (STIs).

The main types of contraceptive devices include male contraceptive devices, female contraceptive devices, female condoms, diaphragms and sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others. Male contraceptive devices, such as condoms and vasectomy procedures, are methods used by men to prevent pregnancy. They include both hormonal and barrier methods. These devices are distributed through various channels, including hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, non-governmental organizations (NGOs), and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The contraceptive devices market research report is one of a series of new reports from The Business Research Company that provides contraceptive devices market statistics, including contraceptive devices industry global market size, regional shares, competitors with a contraceptive devices market share, detailed contraceptive devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive devices industry. This contraceptive devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contraceptive devices market size has grown strongly in recent years. It will grow from $12.8 billion in 2024 to $13.55 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to growing awareness about the importance of family planning and contraceptive methods, government initiatives, increasing global population, greater focus on women's health and empowerment, improving access to healthcare facilities.

The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $17.25 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing awareness of sexual health and STD prevention, economic benefits of controlling family size, growing cultural acceptance of contraceptive use, high proportion of young population in reproductive age, influence of social media on spreading awareness. Major trends in the forecast period include innovations in contraceptive technologies, educational campaigns by NGOs and health organizations advancements in pharmaceutical formulations, availability of a wide range of contraceptive products, investment in research and development for new contraceptive methods.

The forecast of 6.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hormone-eluting polymers and intrauterine device placement systems, sourced from key regions such as the Netherlands and Ireland, which could lead to reduced family planning options and increased reproductive healthcare costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive growth in the contraceptive device market. STDs are infections primarily spread through sexual contact, affecting various body parts and potentially causing a range of symptoms and health issues. Rising STD rates are linked to factors such as higher sexual activity, inadequate protection, insufficient sexual health education, and difficulties accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for preventing STDs as they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For example, a report by the UK Health Security Agency in July 2024 noted 401,800 new STI diagnoses in England in 2023, a 4.7% increase from the previous year's 383,789 cases. Gonorrhoea diagnoses rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while infectious syphilis diagnoses increased by 9.4%, from 8,693 in 2022 to 9,513 in 2023. This growing prevalence of STDs is driving demand for contraceptive devices.

Companies in the contraceptive device market are focusing on developing innovative products, such as contraceptive vaginal rings, to offer convenient, low-maintenance birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced the EnilloRing. This contraceptive vaginal ring, developed by Xiromed, combines etonogestrel and ethinyl estradiol and is designed for long-term use, remaining in place for three weeks, followed by a one-week ring-free interval.

In December 2023, Aditxt, a US-based life sciences company, acquired Evofem Biosciences for $100 million. This acquisition includes Evofem's FDA-approved hormone-free contraceptive gel, Phexxi(R) (lactic acid, citric acid, and potassium bitartrate). Aditxt aims to use this acquisition to bolster its focus on innovations in autoimmunity, health metrics, life-extending transplant technologies, population health, and women's health. This acquisition enhances Aditxt's collaborative ecosystem and maximizes the potential of its subsidiaries. Evofem Biosciences is a US-based manufacturer of contraceptive devices.

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

North America was the largest region in the contraceptive devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the contraceptive devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contraceptive devices market consists of sales of cervical caps, hormonal injections, emergency contraceptive devices and sterilization products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptive Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptive devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptive devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptive devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Male Contraceptive Devices; Female Contraceptive Devices; Female Condoms, Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices; Sub-Dermal Implants; Others Product Types
  • 2) By Technology: Hormonal Contraceptives; Barrier Contraceptives
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO); Other Distribution Channels
  • Subsegments:
  • 1) By Male Contraceptive Devices: Male Condoms; Vasectomy Devices; Male Contraceptive Injections; Male Contraceptive Pills
  • 2) By Female Contraceptive Devices: Female Condoms; Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices (IUDs); Sub-Dermal Implants; Emergency Contraceptive Devices
  • 3) By Female Condoms: Internal Latex Female Condoms; Non-Latex Female Condoms
  • 4) By Diaphragms And Sponges: Silicone Diaphragms; Latex Diaphragms; Contraceptive Sponges
  • 5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings); Non-Hormonal Vaginal Rings
  • 6) By Intrauterine Devices (IUDs): Copper IUDs; Hormonal IUDs; Non-Hormonal IUDs
  • 7) By Sub-Dermal Implants: Hormonal Implants; Non-Hormonal Implants
  • 8) By Other Product Types: Contraceptive Patches; Contraceptive Injections; Contraceptive Pills; Contraceptive Gel And Creams
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Organon Group; Hologic Inc.; CooperSurgical Inc.; Cipla Inc.; Mankind Pharma Ltd.; TTK HealthCare Ltd.; Zondervan; Merck Sharp & Dohme Corp.; Evofem Biosciences Inc.; Veru Inc.; Medisafe Inc.; Agile Therapeutics Inc.; Janssen Global Services LLC; HLL Lifecare Ltd.; Mayer Laboratories Inc.; V-Care Pharma Pvt. Ltd.; Vardhaman Lifecare Pvt. Ltd.; Actavis Pharma LLC; Pregna International Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contraceptive Devices Market Characteristics

3. Contraceptive Devices Market Trends And Strategies

4. Contraceptive Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Contraceptive Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contraceptive Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contraceptive Devices Market Growth Rate Analysis
  • 5.4. Global Contraceptive Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contraceptive Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contraceptive Devices Total Addressable Market (TAM)

6. Contraceptive Devices Market Segmentation

  • 6.1. Global Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Female Condoms, Diaphragms And Sponges
  • Vaginal Rings
  • Intrauterine Devices
  • Sub-Dermal Implants
  • Others Product Types
  • 6.2. Global Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hormonal Contraceptives
  • Barrier Contraceptives
  • 6.3. Global Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channels
  • Public Channel And Non-Governmental Organization (NGO)
  • Other Distribution Channels
  • 6.4. Global Contraceptive Devices Market, Sub-Segmentation Of Male Contraceptive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male Condoms
  • Vasectomy Devices
  • Male Contraceptive Injections
  • Male Contraceptive Pills
  • 6.5. Global Contraceptive Devices Market, Sub-Segmentation Of Female Contraceptive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Female Condoms
  • Diaphragms And Sponges
  • Vaginal Rings
  • Intrauterine Devices (IUDs)
  • Sub-Dermal Implants
  • Emergency Contraceptive Devices
  • 6.6. Global Contraceptive Devices Market, Sub-Segmentation Of Female Condoms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Internal Latex Female Condoms
  • Non-Latex Female Condoms
  • 6.7. Global Contraceptive Devices Market, Sub-Segmentation Of Diaphragms And Sponges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Silicone Diaphragms
  • Latex Diaphragms
  • Contraceptive Sponges
  • 6.8. Global Contraceptive Devices Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NuvaRing (And Other Hormonal Vaginal Rings)
  • Non-Hormonal Vaginal Rings
  • 6.9. Global Contraceptive Devices Market, Sub-Segmentation Of Intrauterine Devices (IUDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper IUDs
  • Hormonal IUDs
  • Non-Hormonal IUDs
  • 6.10. Global Contraceptive Devices Market, Sub-Segmentation Of Sub-Dermal Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hormonal Implants
  • Non-Hormonal Implants
  • 6.11. Global Contraceptive Devices Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contraceptive Patches
  • Contraceptive Injections
  • Contraceptive Pills
  • Contraceptive Gel And Creams

7. Contraceptive Devices Market Regional And Country Analysis

  • 7.1. Global Contraceptive Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contraceptive Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptive Devices Market

  • 8.1. Asia-Pacific Contraceptive Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptive Devices Market

  • 9.1. China Contraceptive Devices Market Overview
  • 9.2. China Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptive Devices Market

  • 10.1. India Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptive Devices Market

  • 11.1. Japan Contraceptive Devices Market Overview
  • 11.2. Japan Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptive Devices Market

  • 12.1. Australia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptive Devices Market

  • 13.1. Indonesia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptive Devices Market

  • 14.1. South Korea Contraceptive Devices Market Overview
  • 14.2. South Korea Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptive Devices Market

  • 15.1. Western Europe Contraceptive Devices Market Overview
  • 15.2. Western Europe Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptive Devices Market

  • 16.1. UK Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptive Devices Market

  • 17.1. Germany Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptive Devices Market

  • 18.1. France Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptive Devices Market

  • 19.1. Italy Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptive Devices Market

  • 20.1. Spain Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptive Devices Market

  • 21.1. Eastern Europe Contraceptive Devices Market Overview
  • 21.2. Eastern Europe Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptive Devices Market

  • 22.1. Russia Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptive Devices Market

  • 23.1. North America Contraceptive Devices Market Overview
  • 23.2. North America Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptive Devices Market

  • 24.1. USA Contraceptive Devices Market Overview
  • 24.2. USA Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptive Devices Market

  • 25.1. Canada Contraceptive Devices Market Overview
  • 25.2. Canada Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptive Devices Market

  • 26.1. South America Contraceptive Devices Market Overview
  • 26.2. South America Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptive Devices Market

  • 27.1. Brazil Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptive Devices Market

  • 28.1. Middle East Contraceptive Devices Market Overview
  • 28.2. Middle East Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptive Devices Market

  • 29.1. Africa Contraceptive Devices Market Overview
  • 29.2. Africa Contraceptive Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contraceptive Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contraceptive Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptive Devices Market Competitive Landscape And Company Profiles

  • 30.1. Contraceptive Devices Market Competitive Landscape
  • 30.2. Contraceptive Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptive Devices Market Other Major And Innovative Companies

  • 31.1. Mylan N.V.
  • 31.2. Organon Group
  • 31.3. Hologic Inc.
  • 31.4. CooperSurgical Inc.
  • 31.5. Cipla Inc.
  • 31.6. Mankind Pharma Ltd.
  • 31.7. TTK HealthCare Ltd.
  • 31.8. Zondervan
  • 31.9. Merck Sharp & Dohme Corp.
  • 31.10. Evofem Biosciences Inc.
  • 31.11. Veru Inc.
  • 31.12. Medisafe Inc.
  • 31.13. Agile Therapeutics Inc.
  • 31.14. Janssen Global Services LLC
  • 31.15. HLL Lifecare Ltd.

32. Global Contraceptive Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptive Devices Market

34. Recent Developments In The Contraceptive Devices Market

35. Contraceptive Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Contraceptive Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contraceptive Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contraceptive Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer